{"nct_id":"NCT02595983","title":"The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2015-10","start_date_type":null,"primary_completion_date":"2017-02-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ALNY"]}